Regulation of the NF-κB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation

被引:379
作者
Liao, GX [1 ]
Zhang, MY [1 ]
Harhaj, EW [1 ]
Sun, SC [1 ]
机构
[1] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA
关键词
D O I
10.1074/jbc.M403286200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The NF-kappaB family of transcription factors plays a pivotal role in regulation of diverse biological processes, including immune responses, cell growth, and apoptosis. Activation of NF-kappaB is mediated by both canonical and noncanonical signaling pathways. Although the canonical pathway has been extensively studied, the mechanism mediating the noncanonical pathway is still poorly understood. Recent studies have identified the NF-kappaB-inducing kinase (NIK) as a key component of the noncanonical pathway of NF-kappaB activation; however, how the signaling function of NIK is regulated remains unknown. We report here that one important mechanism of NIK regulation is through its dynamic interaction with the tumor necrosis factor receptor-associated factor 3 (TRAF3). TRAF3 physically associates with NIK via a specific sequence motif located in the N-terminal region of NIK; this molecular interaction appears to target NIK for degradation by the proteasome. Interestingly, induction of noncanonical NF-kappaB signaling by extracellular signals involves degradation of TRAF3 and the concomitant enhancement of NIK expression. These results suggest that induction of noncanonical NF-kappaB signaling may involve the rescue of NIK from TRAF3-mediated negative regulation.
引用
收藏
页码:26243 / 26250
页数:8
相关论文
共 48 条
[1]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[2]   THE V-REL ONCOGENE ENCODES A KAPPA-B ENHANCER BINDING-PROTEIN THAT INHIBITS NF-KAPPA-B FUNCTION [J].
BALLARD, DW ;
WALKER, WH ;
DOERRE, S ;
SISTA, P ;
MOLITOR, JA ;
DIXON, EP ;
PEFFER, NJ ;
HANNINK, M ;
GREENE, WC .
CELL, 1990, 63 (04) :803-814
[3]   Control of apoptosis by Rel/NF-κB transcription factors [J].
Barkett, M ;
Gilmore, TD .
ONCOGENE, 1999, 18 (49) :6910-6924
[4]   Tumor necrosis factor receptor-associated factors (TRAFs) [J].
Bradley, JR ;
Pober, JS .
ONCOGENE, 2001, 20 (44) :6482-6491
[5]   Regulation of TRAF2 signaling by self-induced degradation [J].
Brown, KD ;
Hostager, BS ;
Bishop, GA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (22) :19433-19438
[6]   Inhibiting the p53-MDM2 interaction:: An important target for cancer therapy [J].
Chène, P .
NATURE REVIEWS CANCER, 2003, 3 (02) :102-109
[7]   BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells [J].
Claudio, E ;
Brown, K ;
Park, S ;
Wang, HS ;
Siebenlist, U .
NATURE IMMUNOLOGY, 2002, 3 (10) :958-965
[8]   CD40 regulates the processing of NF-κB2 p100 to p52 [J].
Coope, HJ ;
Atkinson, PGP ;
Huhse, B ;
Belich, M ;
Janzen, J ;
Holman, MJ ;
Klaus, GGB ;
Johnston, LH ;
Ley, SC .
EMBO JOURNAL, 2002, 21 (20) :5375-5385
[9]   The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways [J].
Dejardin, E ;
Droin, NM ;
Delhase, M ;
Haas, E ;
Cao, YX ;
Makris, C ;
Li, ZW ;
Karin, M ;
Ware, CF ;
Green, DR .
IMMUNITY, 2002, 17 (04) :525-535
[10]   RelB/p50 dimers are differentially regulated by tumor necrosis factor-α and lymphotoxin-β receptor activation -: Critical roles for p100 [J].
Derudder, E ;
Dejardin, E ;
Pritchard, LL ;
Green, DR ;
Körner, M ;
Baud, V .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (26) :23278-23284